✨ New Arrivals Just Dropped!Explore
1 / 2
Respiratory Test Kit Sofia® 2 Sars Antigen+ 25 Tests Clia Waived
- Sofia 2 SARS Antigen+ FIA received De Novo FDA clearance on March 8, 2023
- Sofia 2 SARS Antigen+ Fluorescent Immunoassay (FIA), uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from SARS-CoV-2
- The Sofia 2 SARS Antigen+ FIA, with the Sofia 2 analyzer, provides automated and objective results in 10 minutes, allowing for COVID-19 testing of symptomatic patients when serial testing is started within 6 days of symptom onset
- Sofia 2 SARS Antigen+ FIA is the first FDA-cleared, 10-minute rapid antigen test for COVID-19
- Rapid results to support efficient dispositioning of patients
- Reliable results without cross-reactivity to seasonal coronaviruses
- Virena connection: Provides automated tracking, data capture, government reporting, and exclusive disease mapping
- Ready for use with Sofia 2 for nasal swab procedure
- Includes positive and negative controls
- The test does not differentiate between SARS-CoV and SARS-CoV-2
- A negative test result is presumptive, and it is recommended these results be confirmed by a molecular SARS-CoV-2 assay
- Negative results do not preclude SARS-CoV-2 infections and should not be used as the sole basis for treatment or other patient management decisions
- Positive results do not rule out co-infection with other respiratory pathogens
- This test is intended for prescription use only and can be used in Point-of-Care settings
- Materials Not Supplied in Kit: Timer or watch, Sofia 2 Instrument, Calibration Cassette
- Sofia 2 SARS Antigen+ FIA received De Novo FDA clearance on March 8, 2023
- Sofia 2 SARS Antigen+ Fluorescent Immunoassay (FIA), uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from SARS-CoV-2
- The Sofia 2 SARS Antigen+ FIA, with the Sofia 2 analyzer, provides automated and objective results in 10 minutes, allowing for COVID-19 testing of symptomatic patients when serial testing is started within 6 days of symptom onset
- Sofia 2 SARS Antigen+ FIA is the first FDA-cleared, 10-minute rapid antigen test for COVID-19
- Rapid results to support efficient dispositioning of patients
- Reliable results without cross-reactivity to seasonal coronaviruses
- Virena connection: Provides automated tracking, data capture, government reporting, and exclusive disease mapping
- Ready for use with Sofia 2 for nasal swab procedure
- Includes positive and negative controls
- The test does not differentiate between SARS-CoV and SARS-CoV-2
- A negative test result is presumptive, and it is recommended these results be confirmed by a molecular SARS-CoV-2 assay
- Negative results do not preclude SARS-CoV-2 infections and should not be used as the sole basis for treatment or other patient management decisions
- Positive results do not rule out co-infection with other respiratory pathogens
- This test is intended for prescription use only and can be used in Point-of-Care settings
- Materials Not Supplied in Kit: Timer or watch, Sofia 2 Instrument, Calibration Cassette
Select Packaging
From $166.03
Original: $553.45
-70%Respiratory Test Kit Sofia® 2 Sars Antigen+ 25 Tests Clia Waived—
$553.45
$166.03Description
- Sofia 2 SARS Antigen+ FIA received De Novo FDA clearance on March 8, 2023
- Sofia 2 SARS Antigen+ Fluorescent Immunoassay (FIA), uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from SARS-CoV-2
- The Sofia 2 SARS Antigen+ FIA, with the Sofia 2 analyzer, provides automated and objective results in 10 minutes, allowing for COVID-19 testing of symptomatic patients when serial testing is started within 6 days of symptom onset
- Sofia 2 SARS Antigen+ FIA is the first FDA-cleared, 10-minute rapid antigen test for COVID-19
- Rapid results to support efficient dispositioning of patients
- Reliable results without cross-reactivity to seasonal coronaviruses
- Virena connection: Provides automated tracking, data capture, government reporting, and exclusive disease mapping
- Ready for use with Sofia 2 for nasal swab procedure
- Includes positive and negative controls
- The test does not differentiate between SARS-CoV and SARS-CoV-2
- A negative test result is presumptive, and it is recommended these results be confirmed by a molecular SARS-CoV-2 assay
- Negative results do not preclude SARS-CoV-2 infections and should not be used as the sole basis for treatment or other patient management decisions
- Positive results do not rule out co-infection with other respiratory pathogens
- This test is intended for prescription use only and can be used in Point-of-Care settings
- Materials Not Supplied in Kit: Timer or watch, Sofia 2 Instrument, Calibration Cassette
